Advertisement

Supply Chain



Mallinckrodt Pharmaceuticals withdrew its membership from the Pharmaceutical Research and Manufacturers of America, an influential drug lobby group, reports Business Insider.

While many critics have called for streamlining the Food and Drug Administration's approval process, a new analysis published in the New England Journal of Medicine shows the agency approved a higher amount of drugs at a quicker rate than its…

Advertisement

Most Read

Advertisement
Advertisement